av/aptevo-therapeutics--big.svg

NASDAQ:APVO

Aptevo Therapeutics

  • Stock

USD

Last Close

1.47

06/11 22:27

Market Cap

2.78M

Beta: 5.32

Volume Today

406.93K

Avg: 60.96K

PE Ratio

0.07

PFCF: −0.27

OverviewFinancialsAPI

    Description

    Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company'...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -80-60-40-202018-12-312020-11-102021-12-312023-08-102024-11-07

    Revenue (Estimate*)

    5M10M2018-12-312020-11-102021-12-312023-08-102024-11-07

    *Estimate based on analyst consensus